Background: In vitro diagnostic (IVD) investigations are indispensable for routine patient management. Appropriate testing allows early-stage interventions, reducing late-stage healthcare expenditure (HCE).
Aim: To investigate HCE on IVDs in two developed markets and to assess the perceived value of IVDs on clinical decision-making.